Gene Symbol | CNR1 |
Entrez ID | 1268 |
Uniprot ID | P21554 |
Description | cannabinoid receptor 1 (brain) |
Chromosomal Location | chr6: 88,139,864-88,166,359 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002866 |
positive regulation of acute inflammatory response to antigenic stimulus |
Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus. |
IEA |
BP |
GO:0007187 |
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. |
TAS |
BP |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through activation or inhibition of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP (cAMP). |
IDA |
BP |
GO:0007283 |
spermatogenesis |
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis. |
IEA |
BP |
GO:0007413 |
axonal fasciculation |
The collection of axons into a bundle of rods, known as a fascicle. |
IEA |
BP |
GO:0007568 |
aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
IEA |
BP |
GO:0007584 |
response to nutrient |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
IEA |
BP |
GO:0007613 |
memory |
The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
IEA |
BP |
GO:0010976 |
positive regulation of neuron projection development |
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
IEA |
BP |
GO:0019233 |
sensory perception of pain |
The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process. |
IEA |
BP |
GO:0031622 |
positive regulation of fever generation |
Any process that activates or increases the frequency, rate, or extent of fever generation. |
IEA |
BP |
GO:0031999 |
negative regulation of fatty acid beta-oxidation |
Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid beta-oxidation. |
IEA |
BP |
GO:0032228 |
regulation of synaptic transmission, GABAergic |
Any process that modulates the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). |
IEA |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IEA |
BP |
GO:0033004 |
negative regulation of mast cell activation |
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation. |
IEA |
BP |
GO:0033602 |
negative regulation of dopamine secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of dopamine. |
IEA |
BP |
GO:0035094 |
response to nicotine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
IEA |
BP |
GO:0038171 |
cannabinoid signaling pathway |
The series of molecular signals generated as a consequence of a cannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids. |
IEA |
BP |
GO:0042220 |
response to cocaine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant. |
IEA |
BP |
GO:0042593 |
glucose homeostasis |
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
IEA |
BP |
GO:0043065 |
positive regulation of apoptotic process |
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
IEA |
BP |
GO:0043271 |
negative regulation of ion transport |
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0043278 |
response to morphine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid, isolated from opium, with a complex ring structure. |
IEA |
BP |
GO:0045471 |
response to ethanol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
IEA |
BP |
GO:0045759 |
negative regulation of action potential |
Any process that stops, prevents, or reduces the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels. |
IEA |
BP |
GO:0045776 |
negative regulation of blood pressure |
Any process in which the force of blood traveling through the circulatory system is decreased. |
IEA |
BP |
GO:0045777 |
positive regulation of blood pressure |
Any process in which the force of blood traveling through the circulatory system is increased. |
IEA |
BP |
GO:0050796 |
regulation of insulin secretion |
Any process that modulates the frequency, rate or extent of the regulated release of insulin. |
IEA |
BP |
GO:0051001 |
negative regulation of nitric-oxide synthase activity |
Any process that stops or reduces the activity of the enzyme nitric-oxide synthase. |
IEA |
BP |
GO:0051966 |
regulation of synaptic transmission, glutamatergic |
Any process that modulates the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. |
IEA |
BP |
GO:0060135 |
maternal process involved in female pregnancy |
A reproductive process occurring in the mother that allows an embryo or fetus to develop within it. |
IEA |
BP |
GO:0060259 |
regulation of feeding behavior |
Any process that modulates the rate, frequency or extent of the behavior associated with the intake of food. |
IEA |
BP |
GO:0060405 |
regulation of penile erection |
Any process that modulates the rate, frequency or extent of penile erection. Penile erection is the hardening, enlarging and rising of the penis which often occurs in the sexually aroused male and enables sexual intercourse. Achieved by increased inflow of blood into the vessels of erectile tissue, and decreased outflow. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
CC |
GO:0030424 |
axon |
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
IEA |
CC |
GO:0030426 |
growth cone |
The migrating motile tip of a growing nerve cell axon or dendrite. |
IEA |
CC |
GO:0043231 |
intracellular membrane-bounded organelle |
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
IEA |
CC |
GO:0045121 |
membrane raft |
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
IEA |
MF |
GO:0004949 |
cannabinoid receptor activity |
Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids. |
IDA |
MF |
GO:0008144 |
drug binding |
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease. |
IEA |
Domain ID | Description |
---|---|
IPR000276 |
G protein-coupled receptor, rhodopsin-like |
IPR000810 |
Cannabinoid receptor type 1 |
IPR002230 |
Cannabinoid receptor family |
IPR017452 |
GPCR, rhodopsin-like, 7TM |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04015 |
Rap1 signaling pathway |
KEGG |
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04723 |
Retrograde endocannabinoid signaling |
KEGG |
WP455 |
GPCRs, Class A Rhodopsin-like |
WikiPathways |
WP3679 |
Cell-type Dependent Selectivity of CCK2R Signaling |
WikiPathways |
WP117 |
GPCRs, Other |
WikiPathways |
WP2380 |
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
WikiPathways |
WP247 |
Small Ligand GPCRs |
WikiPathways |
h_cb1rPathway |
Metabolism of Anandamide, an Endogenous Cannabinoid |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0003469 |
Anxiety Disorders |
C0007370 |
Catalepsy |
C0014175 |
Endometriosis |
C0014556 |
Epilepsy, Temporal Lobe |
C0020179 |
Huntington Disease |
C0020429 |
Hyperalgesia |
C0020649 |
Hypotension |
C0020672 |
Hypothermia, Natural |
C0023890 |
Liver Cirrhosis |
C0023893 |
Liver Cirrhosis, Experimental |
C0024809 |
Marijuana Abuse |
C0026650 |
Movement Disorders |
C0026769 |
Multiple Sclerosis |
C0026838 |
Muscle Spasticity |
C0027746 |
Nerve Degeneration |
C0028754 |
Obesity |
C0030193 |
Pain |
C0030297 |
Pancreatic Neoplasm |
C0030305 |
Pancreatitis |
C0035412 |
Rhabdomyosarcoma |
C0036341 |
Schizophrenia |
C0036572 |
Seizures |
C0038220 |
Status Epilepticus |
C0038587 |
Substance Withdrawal Syndrome |
C0043094 |
Weight Gain |
C0236736 |
Cocaine-Related Disorders |
C0236969 |
Substance-Related Disorders |
C1263846 |
Attention Deficit Hyperactivity Disorder |
Tissue | Cell Type |
---|---|
bronchus |
respiratory epithelial cells |
caudate |
glial cells |
cerebellum |
cells in molecular layer |
cerebral cortex |
glial cells |
cervix, uterine |
glandular cells |
fallopian tube |
glandular cells |
hippocampus |
glial cells |
lung |
macrophages |
lymph node |
non-germinal center cells |
nasopharynx |
respiratory epithelial cells |
parathyroid gland |
glandular cells |
soft tissue |
chondrocytes |
tonsil |
non-germinal center cells |
Database Name |
---|
DisGeNET |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
ADORA2A |
135 |
P29274 |
0.67 |
GNA15 |
2769 |
P30679 |
0.52 |
HCRTR1 |
3061 |
O43613 |
0.52 |
MET |
4233 |
P08581 |
0.52 |
RAP1GAP |
5909 |
P47736 |
0.63 |
GNAI1 |
2770 |
P63096 |
0.73 |
GNAI2 |
2771 |
P04899 |
0.73 |
GNAI3 |
2773 |
P08754 |
0.73 |